Nano Labs Ltd. Sponsored ADR NA
2.38
0.06
2.59%
as of 25 Sep
- Market cap
- $56.7M
- P/E
- —
Follow NA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
EV/Sales |
— | — | — | — |
+7 more quarters Free account |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.32 | 0.28 | 0.53 | 0.16 | |
Current Ratio |
1.20 | 2.09 | 1.81 | 1.75 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
27.19% | 16.95% | 44.02% | 28.58% | |
Debt/Equity |
0.52 | 0.26 | 1.05 | 0.76 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.15 | 0.24 | (3.13) | |
Intangible Assets out of Total Assets |
0.06 | 0.04 | 0.03 | 0.08 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(8.21) | (15.15) | (6.89) | (24.44) | |
Working Capital |
5.02 | 31.99 | 77.50 | 21.87 | |
Capital Expenditures |
0.00 | 0.26 | 0.21 | (5.06) | |
Net Current Asset Value |
(21.17) | 7.44 | 52.96 | (2.28) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.18 | 1.50 | 0.16 | 0.14 | |
Average Payables |
1.82 | 2.66 | 2.81 | 5.16 | |
Average Inventory |
1.04 | 1.59 | 3.41 | 4.98 | |
Average Assets |
82.00 | 105.24 | 127.94 | 63.38 | |
Average Common Equity |
30.30 | 50.62 | 42.09 | 18.41 |
Columns are period end dates